Primary Care Physicians Can Better Manage the Total Cost of Care for an Accountable Care Population

Primary Care Physicians Can Better Manage the Total Cost of Care for an Accountable Care Population

SAN MATEO, Calif.–(BUSINESS WIRE)–Primary care physicians (“PCPs”) can more effectively manage the total cost of care when managing the healthcare needs of a covered population. Cave Consulting Group (“CCGroup”) reached this conclusion after evaluating the performance of several health plan accountable care and value-based reimbursement programs.

“On average, PCPs are involved in treating 57% of all prevalent medical condition episodes of care. This means patients are self-referring to specialists 43% of the time,” stated Dr. Douglas G. Cave, President of CCGroup. Continue reading

National Specialist Panels Uphold Established Clinical MedMarker Protocol Ranges™

National Specialist Panels Uphold Established Clinical MedMarker Protocol Ranges™

SAN MATEO, Calif.–(BUSINESS WIRE)–Nationally over 230,000 primary care physicians (PCPs) and specialists are evaluated based on achieving acceptable clinical protocol ranges in treating medical conditions (or Clinical MedMarker Protocol Ranges™). “CCGroup works with CCGroup National Specialist Panels on an ongoing basis. This effort helps to ensure the validity of established Clinical MedMarker Protocol Ranges™,” stated Dr. Douglas G. Cave, President of CCGroup. CCGroup is the market innovator and leader in reliably measuring physician efficiency. Dr. Cave continued, “MedMarkers™ are process of care quality measures, well-defined in clinical guidelines. However, they also are the key services and procedures most associated with cost-of-care in treating a medical condition. MRI of spine is the main MedMarker™ (or correlated service) in treating low back pain; and upper gastrointestinal (GI) endoscopy is the main MedMarker™ in treating GERD (or heartburn). MedMarkers™ technology is protected under USPTO Patent Numbers 8,301,464 and 8,751,263.”

Read full article here.

Foundation for Successful, Provider Value-Based Payment Programs

Foundation for Successful, Provider Value-Based Payment Programs

SAN MATEO, Calif.–(BUSINESS WIRE)–CCGroup is the market innovator and leader in reliably measuring physician efficiency. Just one year ago, a California federal jury awarded Cave Consulting Group, Inc. (CCGroup) more than $12 million after determining that OptumInsight’s Impact Intelligence infringes CCGroup’s patent for measuring physician efficiency. “No other competitor to CCGroup is allowed to offer our analytics, methods, and system – unless they have a license from CCGroup to do so,” declared Dr. Douglas G. Cave, President of CCGroup.

Read full article here.

CCGroup Seeks Injunction Against OptumInsight’s Impact Intelligence Software

CCGroup Seeks Injunction Against OptumInsight’s Impact Intelligence Software

SAN MATEO, Calif.–(BUSINESS WIRE)–A California federal jury determined that UnitedHealth Group’s subsidiary OptumInsight infringed Cave Consulting Group’s patent for measuring physician efficiency. The federal jury determined that OptumInsight infringed the U.S. Patent No. 7,739,126 (“‘126 patent”) by operating and licensing its Impact Intelligence software, a competing solution for developing physician efficiency scores. Continue reading

Jury Awards Cave Consulting Group $12 Million for Patent Infringement

Jury Awards Cave Consulting Group $12 Million for Patent Infringement

SAN MATEO, Calif.–(BUSINESS WIRE)–A California federal jury on Friday, April 3, 2015 awarded Cave Consulting Group, Inc. more than $12 million after determining that UnitedHealth Group’s subsidiary OptumInsight infringed Cave Consulting Group’s patent for measuring physician efficiency. The jury also rejected OptumInsight’s counterclaim that Cave Consulting Group infringed OptumInsight’s patent for processing medical claims data. Cave Consulting Group’s U.S. Patent No. 7,739,126 (the “‘126 patent”) protects its advanced approach to analyzing physician efficiency, which enables health plans, physician groups and others to obtain accurate and reliable physician efficiency scores—increasingly vital statistical measures used to combat rising healthcare costs. CCGroup’s patented physician efficiency method is considered the de facto standard for determining physician efficiency in the healthcare industry today.

Read full article here.

Cave Consulting Group, Inc. Prevails In Numerous Patent Infringement Disputes With OptumInsight, Inc.

Cave Consulting Group, Inc. Prevails In Numerous Patent Infringement Disputes With OptumInsight, Inc.

SAN MATEO, Calif.–(BUSINESS WIRE)–CCGroup is pleased to announce that it has prevailed on many of the patent infringement claims asserted against it by OptumInsight (formerly Ingenix, Inc.). OptumInsight’s claims of infringement for 6 of its 8 asserted patents, which pertained to grouping medical claims data into episode treatment groups (“ETGs”), have been dismissed by the court and cannot be reasserted. “OptumInsight has acknowledged that CCGroup has prevailed against the Symmetry ETG portfolio of patents,” stated Dr. Douglas G. Cave, President of CCGroup. Two OptumInsight patents, which expire next year, remain in suit. For the same reasons OptumInsight has dismissed a majority of its patent claims, CCGroup is confident that it will prevail on OptumInsight’s remaining claims asserted against the Cave Grouper™.

Read full article here.

U.S. Patents Issued to Protect Cave Consulting Group’s (“CCGroup”) Physician Efficiency Measurement Using Episodes-of-Care and a Predefined Set of Medical Conditions

U.S. Patents Issued to Protect Cave Consulting Group’s (“CCGroup”) Physician Efficiency Measurement Using Episodes-of-Care and a Predefined Set of Medical Conditions

U.S. Patents Issued to Protect Cave Consulting Group’s (“CCGroup”) Physician Efficiency Measurement Using Episodes-of-Care and a Predefined Set of Medical Conditions 

San Mateo, CA. – CCGroup is pleased to announce that the United States Patent and Trademark Office has issued a fourth patent to CCGroup, protecting its physician efficiency methodology and system. The four (4) patents are U.S. Patent Nos. 7,739,1268,301,4648,340,981; and 8,639,528, the most recently issued. Other patent applications are awaiting approval. Continue reading

Virginia Mason Practices in the Appropriate Clinical Protocol Range for MRI of Spine Use in Diagnostics for Low Back Pain

Virginia Mason Practices in the Appropriate Clinical Protocol Range for MRI of Spine Use in Diagnostics for Low Back Pain

SAN MATEO, Calif.–(BUSINESS WIRE)–CCGroup is pleased to announce that Virginia Mason Medical Center (Virginia Mason) in Seattle, Wash. continues to practice in the appropriate Clinical MedMarker™ Protocol Range for utilizing MRI of Spine in diagnostics for routine, non-complicated low back pain (LBP) patient episodes-of-care.

This news is not surprising to Robert Mecklenburg, MD, Medical Director of the Center for Healthcare Solutions at Virginia Mason. “In 2005, the medical center pursued efficiency in its spine clinic by adopting systems engineering methods of Toyota Motor Corp. As we published in the Wall Street Journal in 2007, back pain patients now follow a more standardized path. They have an initial combined visit with a physical therapist and a doctor,” Dr. Mecklenburg said. “We developed evidence-based decision rules and embedded them in the scheduling process for radiology. If the provider could not document the evidence-based indication for the imaging study on the scheduling screen, then the test could not be ordered.” He continued, “Within a year, the imaging rate of MRI of Spine decreased 23% across the enterprise.” Continue reading

CCGroup Develops Acceptable Clinical Protocol Range for MRI of Spine in Treating Low Back Pain

CCGroup Develops Acceptable Clinical Protocol Range for MRI of Spine in Treating Low Back Pain

San Mateo, CA. – CCGroup is pleased to announce that the company has developed an acceptable clinical protocol range for utilizing MRI of Spine in diagnostics for routine, non-complicated low back pain (LBP) patient episodes-of-care.  CCGroup BullsEye™ statistical analysis and methodologies (protected by U.S. Patent No. 8,301,464) strongly correlates MRI of Spine as the key diagnostic service to orthopedists’ efficiency score in treating non-complicated LBP.  Therefore, MRI of Spine is the MedMarker™ (or correlated service) in treating non-complicated LBP. Continue reading

CCGroup Develops Acceptable Clinical Protocol Range for Upper GI Endoscopy Use in Treating Gastroesophagel (GERD)

CCGroup Develops Acceptable Clinical Protocol Range for Upper GI Endoscopy Use in Treating Gastroesophagel (GERD)

Cave Consulting Group (“CCGroup”) Develops Acceptable Clinical Protocol Range for Upper GI Endoscopy Use in Treating Gastroesophageal (GERD)

February 22, 2013

San Mateo, CA. – CCGroup is pleased to announce that the company has developed an acceptable clinical protocol range for utilizing upper gastrointestinal (GI) endoscopies in treating routine, noncomplicated GERD (or heartburn) patient episodes-of-care. CCGroup BullsEye™ statistical analysis and methodologies (protected by U.S. Patent No. 8,301,464) strongly correlates upper GI endoscopies as the key procedure to gastroenterologists’ efficiency score in treating noncomplicated GERD. Therefore, upper GI endoscopy is the MedMarker™ (or correlated service) in treating non-complicated GERD. Continue reading